When refining a return-to-work program, employers can often overlook this one, crucial element: The interactions medications have on their injured workers.
A panel at the 2019 National Workers’ Compensation and Disability Conference® & Expo titled “The Opioid Epidemic: Mitigating Employee Safety and Health Risks” drew audience attention to alternatives that are helping curb the crisis.
Nuclear verdicts are on the rise in the United States, but according to these legal professionals, jury consulting is a prime way to mitigate the risk.
A lack of product standardization, the new federal legality of some types of CBD and ever changing state regulations are just some of the issues facing the medical cannabis community.
Two non-psychoactive molecules from the Cannabis sativa L plant have the potential to replace opioids with a new drug that poses zero-impairment issues for users.
News that Purdue is exploring filing for Chapter 11 bankruptcy suggests the company might be trying to avoid financial liability in opioid-related suits.
Workers’ comp needs a better solution for opioids than more prescription opportunities. And luckily, numerous alternative treatments are already at our fingertips.